Aminoglycosides: old friend ... new foe?

被引：0
作者：
Simmonds, N. J. [1 ]
Thomson, A. H. [2 ]
机构：
[1] Royal Brompton Hosp Imperial Coll, Adult Cyst Fibrosis Ctr, Sydney St, London SW3 6NP, England
[2] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland
来源：
JOURNAL OF CYSTIC FIBROSIS | 2016年 / 15卷 / 04期
关键词：
CYSTIC-FIBROSIS; TOBRAMYCIN TREATMENT; FREQUENCY;
D O I：
10.1016/j.jcf.2016.05.011
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：411 / 412
页数：2
相关论文
共 9 条
  • [1] Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
    Al-Aloul, M
    Miller, H
    Alapati, S
    Stockton, PA
    Ledson, MJ
    Walshaw, MJ
    [J]. PEDIATRIC PULMONOLOGY, 2005, 39 (01) : 15 - 20
  • [2] High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis
    Al-Malky, Ghada
    Dawson, Sally J.
    Sirimanna, Tony
    Bagkeris, Emmanouil
    Suri, Ranjan
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (02) : 248 - 254
  • [3] Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis
    Alghanem, Sarah
    Paterson, Iona
    Touw, Daan J.
    Thomson, Alison H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1338 - 1347
  • [4] Future trends in cystic fibrosis demography in 34 European countries
    Burgel, Pierre-Regis
    Bellis, Gil
    Olesen, Hanne V.
    Viviani, Laura
    Zolin, Anna
    Blasi, Francesco
    Elborn, J. Stuart
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (01) : 133 - 141
  • [5] Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population
    Conrad, Douglas J.
    Stenbit, Antine E.
    Zettner, Erika M.
    Wick, Ivan
    Eckhardt, Colleen
    Hardiman, Gary
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (12) : 1095 - 1102
  • [6] D-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models
    Fox, Daniel J.
    Cooper, Morris D.
    Speil, Cristian A.
    Roberts, Melissa H.
    Yanik, Susan C.
    Meech, Robert P.
    Hargrove, Tim L.
    Verhulst, Steven J.
    Rybak, Leonard P.
    Campbell, Kathleen C. M.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (04) : 518 - 530
  • [7] CUMULATIVE AND ACUTE TOXICITY OF REPEATED HIGH-DOSE TOBRAMYCIN TREATMENT IN CYSTIC-FIBROSIS
    PEDERSEN, SS
    JENSEN, T
    OSTERHAMMEL, D
    OSTERHAMMEL, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) : 594 - 599
  • [8] The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
    Prayle, A. P.
    Jain, K.
    Touw, D. J.
    Koch, B. C. P.
    Knox, A. J.
    Watson, A.
    Smyth, A. R.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (04) : 510 - 517
  • [9] Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study: a randomised controlled trial
    Smyth, A
    Tan, KHV
    Hyman-Taylor, P
    Mulheran, M
    Lewis, S
    Stableforth, D
    Knox, A
    [J]. LANCET, 2005, 365 (9459) : 573 - 578
1